newsroom

December 29, 2011
Marshall Edwards Adds $2 Million in Private Placement
[ View full article ]
December 20, 2011
Marshall Edwards Awarded Key Patent for Compositions of Lead Oncology Drug Candidates
[ View full article ]
November 22, 2011
Marshall Edwards to Host Annual Meeting of Stockholders
[ View full article ]
November 10, 2011
Marshall Edwards CEO to Present at Lazard Capital Markets Healthcare Conference
[ View full article ]
October 27, 2011
Marshall Edwards and Ausio Pharmaceuticals Announce Exclusive License Agreement
[ View full article ]
October 24, 2011
Marshall Edwards Appoints Healthcare Investment Banking Veteran Charles Baltic to Board of Directors
[ View full article ]
September 28, 2011
Marshall Edwards Announces $2 Million Private Placement
[ View full article ]
September 19, 2011
Marshall Edwards Announces First Patient Dosed in Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
[ View full article ]
September 8, 2011
Marshall Edwards Announces Initiation of Phase I Clinical Trial of Lead Oncology Drug Candidate ME-143
[ View full article ]
August 24, 2011
Marshall Edwards CEO to Present at Southern California Investor Conference
[ View full article ]
August 16, 2011
Marshall Edwards Announces FDA Approval of Investigational New Drug Application for Lead Candidate ME-143
[ View full article ]
July 27, 2011
Marshall Edwards Announces Publication of Pre-Clinical Study Showing Activity in Chemotherapy-Resistant Ovarian Cancer Stem Cells
[ View full article ]
June 27, 2011
Marshall Edwards Announces Publication of Pre-Clinical Studies in Pancreatic Cancer
[ View full article ]
June 2, 2011
Marshall Edwards Adds Former Genentech Head of Medical Affairs Robert Mass as Chief Medical Officer
[ View full article ]
May 10, 2011
Marshall Edwards Announces Closing of Asset Purchase Agreement with Novogen
[ View full article ]
May 2, 2011
Marshall Edwards Announces Private Placement
[ View full article ]
April 14, 2011
Marshall Edwards Announces Election of William Rueckert to Board of Directors
[ View full article ]
March 31, 2011
Marshall Edwards CEO to Present at Needham Healthcare Conference
[ View full article ]
March 29, 2011
Marshall Edwards to Report New Data on Mitochondrial Inhibitor Program at American Association for Cancer Research Annual Meeting
[ View full article ]
March 21, 2011
Marshall Edwards Announces Publication of Phase II Clinical Trial Results Highlighting Activity of Intravenous Phenoxodiol
[ View full article ]
March 16, 2011
Marshall Edwards Receives Positive Response from NASDAQ
[ View full article ]
March 10, 2011
Marshall Edwards to Host Annual Meeting of Stockholders
[ View full article ]
February 8, 2011
Marshall Edwards CEO to Present at BIO CEO & Investor Conference
[ View full article ]